Takeda to sell 21 assets, including Osaka headquarters

Jan 29, 2019

Takeda Pharmaceutical announced plans to sell 21 assets, which includes its Osaka headquarters. The deals are planned to occur during late March and are being done in order to pare down the debt it incurred from its $62 billion Shire acquisition.

The drugmaker will book about $38 million as proceeds from the sale of the assets. Takeda will be transferring ownership to a newly launched subsidiary before selling it to an undisclosed buyer.

Read the Jiji Press report

Don't miss your Daily Dose.  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments